Levodopa-induced dyskinesias related to vicia faba ingestion in a parkinson''s disease patient
Lambea Gil, Alvaro (Universidad de Zaragoza) ; Requena Calleja, María Ángeles ; Horna Cañete, Laura (Universidad de Zaragoza)
Resumen: Levodopa-induced dyskinesias is a well-known side effect in patients with Parkinson’s disease (PD). Several circumstances seem to play a role in its appearance, and some of them can go unnoticed. We want to exemplify the role of a commonly eaten bean, Vicia faba, as a natural source of levodopa. This could interfere with the control of motor symptoms in patients with PD.
Idioma: Inglés
DOI: 10.4103/0028-3886.333436
Año: 2021
Publicado en: NEUROLOGY INDIA 69, 6 (2021), 1878-1879
ISSN: 0028-3886
Factor impacto JCR: 1.663 (2021)
Categ. JCR: NEUROSCIENCES rank: 252 / 275 = 0.916 (2021) - Q4 - T3
Factor impacto CITESCORE: 1.7 - Medicine (Q3) - Neuroscience (Q4)
Factor impacto SCIMAGO: 0.321 - Neurology (clinical) (Q3) - Neurology (Q3)
Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
Exportado de SIDERAL (2023-05-18-16:12:31)
Visitas y descargas
Idioma: Inglés
DOI: 10.4103/0028-3886.333436
Año: 2021
Publicado en: NEUROLOGY INDIA 69, 6 (2021), 1878-1879
ISSN: 0028-3886
Factor impacto JCR: 1.663 (2021)
Categ. JCR: NEUROSCIENCES rank: 252 / 275 = 0.916 (2021) - Q4 - T3
Factor impacto CITESCORE: 1.7 - Medicine (Q3) - Neuroscience (Q4)
Factor impacto SCIMAGO: 0.321 - Neurology (clinical) (Q3) - Neurology (Q3)
Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. Exportado de SIDERAL (2023-05-18-16:12:31)
Permalink:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Medicina
Record created 2022-03-22, last modified 2023-05-19